ArticleBMC pharmacology & toxicology2025

Adverse events associated with IL-23 and IL-12/23 inhibitors in the clinical management of psoriasis: a comprehensive pharmacovigilance analysis.

Wentao Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.